
Prebiotics for infant formula refer to specific types of carbohydrates that are added to infant formula to promote the growth and activity of beneficial bacteria in the baby's digestive system. These prebiotics serve as a food source for the beneficial bacteria, known as probiotics, which are naturally present in the infant's gut or are introduced through the formula. By supporting the growth of these beneficial bacteria, prebiotics help create a favorable environment in the infant's digestive tract, which can have several potential health benefits.
The global market for Prebiotics for Infant Formula was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Prebiotics used in infant formula are typically derived from either human milk or plant sources. The most commonly used prebiotics in infant formula include oligosaccharides such as galacto-oligosaccharides (GOS) and fructo-oligosaccharides (FOS). These prebiotics are structurally similar to the oligosaccharides found in human breast milk, which are known to have important roles in supporting the development of a healthy gut microbiome in infants.
The addition of prebiotics to infant formula aims to mimic the beneficial effects of breastfeeding on the infant's gut health. Research suggests that prebiotics in infant formula can help establish a more balanced and diverse gut microbiota, which may support the development of a healthy immune system, improve digestion, and potentially reduce the risk of certain health conditions, such as allergies and infections.
It's important to note that prebiotics should not be confused with probiotics, which are live bacteria or yeasts that are also sometimes added to infant formula. Prebiotics act as a food source for probiotics, while probiotics themselves are the beneficial live bacteria that can provide direct health benefits when consumed.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Prebiotics for Infant Formula, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Prebiotics for Infant Formula by region & country, by Type, and by Application.
The Prebiotics for Infant Formula market size, estimations, and forecasts are provided in terms of sales volume (Tons) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prebiotics for Infant Formula.
Market Segmentation
By Company
FrieslandCampina
Meiji
Yakult
Baolingbao
Beneo-Orafti
Bailong
Ingredion
Sensus
QHT
Nikon Shikuhin KaKo
Nissin-sugar
Cosucra
Glycom
Jennewein Biotechnologie
Segment by Type:
Fructooligosaccharide
Galactooligosaccharides
Inulin
Human Milk Oligosaccharides
Other
Segment by Application
Standard
Follow on
Toddler
Specialty
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Prebiotics for Infant Formula manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Prebiotics for Infant Formula in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Prebiotics for Infant Formula in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Market Overview
1.1 Prebiotics for Infant Formula Product Introduction
1.2 Global Prebiotics for Infant Formula Market Size Forecast
1.2.1 Global Prebiotics for Infant Formula Sales Value (2019-2030)
1.2.2 Global Prebiotics for Infant Formula Sales Volume (2019-2030)
1.2.3 Global Prebiotics for Infant Formula Sales Price (2019-2030)
1.3 Prebiotics for Infant Formula Market Trends & Drivers
1.3.1 Prebiotics for Infant Formula Industry Trends
1.3.2 Prebiotics for Infant Formula Market Drivers & Opportunity
1.3.3 Prebiotics for Infant Formula Market Challenges
1.3.4 Prebiotics for Infant Formula Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Prebiotics for Infant Formula Players Revenue Ranking (2023)
2.2 Global Prebiotics for Infant Formula Revenue by Company (2019-2024)
2.3 Global Prebiotics for Infant Formula Players Sales Volume Ranking (2023)
2.4 Global Prebiotics for Infant Formula Sales Volume by Company Players (2019-2024)
2.5 Global Prebiotics for Infant Formula Average Price by Company (2019-2024)
2.6 Key Manufacturers Prebiotics for Infant Formula Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Prebiotics for Infant Formula Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Prebiotics for Infant Formula
2.9 Prebiotics for Infant Formula Market Competitive Analysis
2.9.1 Prebiotics for Infant Formula Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Prebiotics for Infant Formula Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prebiotics for Infant Formula as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Fructooligosaccharide
3.1.2 Galactooligosaccharides
3.1.3 Inulin
3.1.4 Human Milk Oligosaccharides
3.1.5 Other
3.2 Global Prebiotics for Infant Formula Sales Value by Type
3.2.1 Global Prebiotics for Infant Formula Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Prebiotics for Infant Formula Sales Value, by Type (2019-2030)
3.2.3 Global Prebiotics for Infant Formula Sales Value, by Type (%) (2019-2030)
3.3 Global Prebiotics for Infant Formula Sales Volume by Type
3.3.1 Global Prebiotics for Infant Formula Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Prebiotics for Infant Formula Sales Volume, by Type (2019-2030)
3.3.3 Global Prebiotics for Infant Formula Sales Volume, by Type (%) (2019-2030)
3.4 Global Prebiotics for Infant Formula Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Standard
4.1.2 Follow on
4.1.3 Toddler
4.1.4 Specialty
4.2 Global Prebiotics for Infant Formula Sales Value by Application
4.2.1 Global Prebiotics for Infant Formula Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Prebiotics for Infant Formula Sales Value, by Application (2019-2030)
4.2.3 Global Prebiotics for Infant Formula Sales Value, by Application (%) (2019-2030)
4.3 Global Prebiotics for Infant Formula Sales Volume by Application
4.3.1 Global Prebiotics for Infant Formula Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Prebiotics for Infant Formula Sales Volume, by Application (2019-2030)
4.3.3 Global Prebiotics for Infant Formula Sales Volume, by Application (%) (2019-2030)
4.4 Global Prebiotics for Infant Formula Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Prebiotics for Infant Formula Sales Value by Region
5.1.1 Global Prebiotics for Infant Formula Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Prebiotics for Infant Formula Sales Value by Region (2019-2024)
5.1.3 Global Prebiotics for Infant Formula Sales Value by Region (2025-2030)
5.1.4 Global Prebiotics for Infant Formula Sales Value by Region (%), (2019-2030)
5.2 Global Prebiotics for Infant Formula Sales Volume by Region
5.2.1 Global Prebiotics for Infant Formula Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Prebiotics for Infant Formula Sales Volume by Region (2019-2024)
5.2.3 Global Prebiotics for Infant Formula Sales Volume by Region (2025-2030)
5.2.4 Global Prebiotics for Infant Formula Sales Volume by Region (%), (2019-2030)
5.3 Global Prebiotics for Infant Formula Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Prebiotics for Infant Formula Sales Value, 2019-2030
5.4.2 North America Prebiotics for Infant Formula Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Prebiotics for Infant Formula Sales Value, 2019-2030
5.5.2 Europe Prebiotics for Infant Formula Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Prebiotics for Infant Formula Sales Value, 2019-2030
5.6.2 Asia Pacific Prebiotics for Infant Formula Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Prebiotics for Infant Formula Sales Value, 2019-2030
5.7.2 South America Prebiotics for Infant Formula Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Prebiotics for Infant Formula Sales Value, 2019-2030
5.8.2 Middle East & Africa Prebiotics for Infant Formula Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Prebiotics for Infant Formula Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Prebiotics for Infant Formula Sales Value
6.2.1 Key Countries/Regions Prebiotics for Infant Formula Sales Value, 2019-2030
6.2.2 Key Countries/Regions Prebiotics for Infant Formula Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Prebiotics for Infant Formula Sales Value, 2019-2030
6.3.2 United States Prebiotics for Infant Formula Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Prebiotics for Infant Formula Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Prebiotics for Infant Formula Sales Value, 2019-2030
6.4.2 Europe Prebiotics for Infant Formula Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Prebiotics for Infant Formula Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Prebiotics for Infant Formula Sales Value, 2019-2030
6.5.2 China Prebiotics for Infant Formula Sales Value by Type (%), 2023 VS 2030
6.5.3 China Prebiotics for Infant Formula Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Prebiotics for Infant Formula Sales Value, 2019-2030
6.6.2 Japan Prebiotics for Infant Formula Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Prebiotics for Infant Formula Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Prebiotics for Infant Formula Sales Value, 2019-2030
6.7.2 South Korea Prebiotics for Infant Formula Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Prebiotics for Infant Formula Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Prebiotics for Infant Formula Sales Value, 2019-2030
6.8.2 Southeast Asia Prebiotics for Infant Formula Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Prebiotics for Infant Formula Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Prebiotics for Infant Formula Sales Value, 2019-2030
6.9.2 India Prebiotics for Infant Formula Sales Value by Type (%), 2023 VS 2030
6.9.3 India Prebiotics for Infant Formula Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 FrieslandCampina
7.1.1 FrieslandCampina Company Information
7.1.2 FrieslandCampina Introduction and Business Overview
7.1.3 FrieslandCampina Prebiotics for Infant Formula Sales, Revenue and Gross Margin (2019-2024)
7.1.4 FrieslandCampina Prebiotics for Infant Formula Product Offerings
7.1.5 FrieslandCampina Recent Development
7.2 Meiji
7.2.1 Meiji Company Information
7.2.2 Meiji Introduction and Business Overview
7.2.3 Meiji Prebiotics for Infant Formula Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Meiji Prebiotics for Infant Formula Product Offerings
7.2.5 Meiji Recent Development
7.3 Yakult
7.3.1 Yakult Company Information
7.3.2 Yakult Introduction and Business Overview
7.3.3 Yakult Prebiotics for Infant Formula Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Yakult Prebiotics for Infant Formula Product Offerings
7.3.5 Yakult Recent Development
7.4 Baolingbao
7.4.1 Baolingbao Company Information
7.4.2 Baolingbao Introduction and Business Overview
7.4.3 Baolingbao Prebiotics for Infant Formula Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Baolingbao Prebiotics for Infant Formula Product Offerings
7.4.5 Baolingbao Recent Development
7.5 Beneo-Orafti
7.5.1 Beneo-Orafti Company Information
7.5.2 Beneo-Orafti Introduction and Business Overview
7.5.3 Beneo-Orafti Prebiotics for Infant Formula Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Beneo-Orafti Prebiotics for Infant Formula Product Offerings
7.5.5 Beneo-Orafti Recent Development
7.6 Bailong
7.6.1 Bailong Company Information
7.6.2 Bailong Introduction and Business Overview
7.6.3 Bailong Prebiotics for Infant Formula Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Bailong Prebiotics for Infant Formula Product Offerings
7.6.5 Bailong Recent Development
7.7 Ingredion
7.7.1 Ingredion Company Information
7.7.2 Ingredion Introduction and Business Overview
7.7.3 Ingredion Prebiotics for Infant Formula Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Ingredion Prebiotics for Infant Formula Product Offerings
7.7.5 Ingredion Recent Development
7.8 Sensus
7.8.1 Sensus Company Information
7.8.2 Sensus Introduction and Business Overview
7.8.3 Sensus Prebiotics for Infant Formula Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Sensus Prebiotics for Infant Formula Product Offerings
7.8.5 Sensus Recent Development
7.9 QHT
7.9.1 QHT Company Information
7.9.2 QHT Introduction and Business Overview
7.9.3 QHT Prebiotics for Infant Formula Sales, Revenue and Gross Margin (2019-2024)
7.9.4 QHT Prebiotics for Infant Formula Product Offerings
7.9.5 QHT Recent Development
7.10 Nikon Shikuhin KaKo
7.10.1 Nikon Shikuhin KaKo Company Information
7.10.2 Nikon Shikuhin KaKo Introduction and Business Overview
7.10.3 Nikon Shikuhin KaKo Prebiotics for Infant Formula Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Nikon Shikuhin KaKo Prebiotics for Infant Formula Product Offerings
7.10.5 Nikon Shikuhin KaKo Recent Development
7.11 Nissin-sugar
7.11.1 Nissin-sugar Company Information
7.11.2 Nissin-sugar Introduction and Business Overview
7.11.3 Nissin-sugar Prebiotics for Infant Formula Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Nissin-sugar Prebiotics for Infant Formula Product Offerings
7.11.5 Nissin-sugar Recent Development
7.12 Cosucra
7.12.1 Cosucra Company Information
7.12.2 Cosucra Introduction and Business Overview
7.12.3 Cosucra Prebiotics for Infant Formula Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Cosucra Prebiotics for Infant Formula Product Offerings
7.12.5 Cosucra Recent Development
7.13 Glycom
7.13.1 Glycom Company Information
7.13.2 Glycom Introduction and Business Overview
7.13.3 Glycom Prebiotics for Infant Formula Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Glycom Prebiotics for Infant Formula Product Offerings
7.13.5 Glycom Recent Development
7.14 Jennewein Biotechnologie
7.14.1 Jennewein Biotechnologie Company Information
7.14.2 Jennewein Biotechnologie Introduction and Business Overview
7.14.3 Jennewein Biotechnologie Prebiotics for Infant Formula Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Jennewein Biotechnologie Prebiotics for Infant Formula Product Offerings
7.14.5 Jennewein Biotechnologie Recent Development
8 Industry Chain Analysis
8.1 Prebiotics for Infant Formula Industrial Chain
8.2 Prebiotics for Infant Formula Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Prebiotics for Infant Formula Sales Model
8.5.2 Sales Channel
8.5.3 Prebiotics for Infant Formula Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
FrieslandCampina
Meiji
Yakult
Baolingbao
Beneo-Orafti
Bailong
Ingredion
Sensus
QHT
Nikon Shikuhin KaKo
Nissin-sugar
Cosucra
Glycom
Jennewein Biotechnologie
Ìý
Ìý
*If Applicable.
